NCT05326087 2026-02-02
Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A
ShangHai Ji Ai Genetics & IVF Institute
Phase 3 Not yet recruiting
Clinical Trials
10 trialsNCT06608186 2025-01-22
PPOS
Benha University
Phase 1/2 Completed
NCT04727671 2023-10-24
Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.
Damascus University
Phase 4 Completed
NCT04727684 2023-10-24
Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI
Damascus University
Phase 4 Completed
NCT04071574 2023-05-09
CS-EOSP-ICSI
Lebanese University
Phase 1/2 Completed
NCT05847660 2023-05-06
Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patient
Fayoum University
Phase NA Unknown
NCT05112692 2021-11-09
Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles
Mansoura University
Phase NA Unknown
NCT04094467 2020-03-25
Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection
Assiut University
Phase 4 Unknown
NCT01402336 2017-10-10
GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer
Seoul National University Hospital
Phase 3 Completed
NCT01185704 2014-02-13
ATTAC-PCO
Merck KGaA, Darmstadt, Germany
Phase 3 Completed